HCA Healthcare Q3 2026 earnings: profit tops forecasts despite payer-mix pressure
HCA beat Wall Street's profit and revenue estimates on steady patient-volume growth, but a rising share of uninsured patients cut into net income.
| Q3 2026 | Reported | Expected | Surprise |
|---|---|---|---|
| EPS | $7.22 | $6.73 | +7.3% |
| Revenue | $19.85B | $19.53B | +1.7% |
Key takeaways
- Adjusted earnings per share of $7.22 beat the $6.73 analysts had expected, and revenue of $19.85 billion also came in above the roughly $19.53 billion forecast.
- Patient volumes kept climbing: same-facility admissions rose 2.7% and equivalent admissions rose 3.0%, which management called the company’s 22nd consecutive quarter of volume growth.
- Even with higher revenue, net income attributable to the company slipped about 4% to roughly $1.58 billion. The culprit was a shift in who’s paying for care: the share of patients who are uninsured rose from 8.5% to 10.5% of equivalent admissions, which management said cut pretax income by about $400 million in the quarter.
- HCA raised its estimate of extra cash coming from state Medicaid “supplemental payment” programs (state funds that help offset what Medicaid normally underpays hospitals) to $600–$800 million for all of 2026, up from the $50 million it booked in this quarter alone — a cushion that partly offset the payer-mix hit.
- Outpatient surgery volume fell 3.7% in the quarter, a soft spot alongside otherwise steady patient demand.
- Management reaffirmed the full-year 2026 guidance ranges it set back in July and said results are now tracking toward the upper half of those ranges — a modest vote of confidence rather than a guidance raise.
- Looking ahead, HCA flagged that the Medicaid supplemental payments boosting 2026 are mostly temporary and could run $550–$650 million lower in 2027 as grandfathered state programs expire, and said it expects overall 2027 earnings to be roughly in line with 2026 rather than higher.
- Underlying profitability remains strong on a trailing-twelve-month basis — HCA converts about 15 cents of every revenue dollar into operating profit and roughly 9 cents into net profit — showing the payer-mix pressure seen this quarter hasn’t derailed the business over the past year.
How the stock took it
HCA Healthcare, Inc. closed at $465.26 on Oct 26, 2026, the last session before the report, and at $463.22 on Oct 28, 2026, the first session after it — -0.4% across the report.
Closes from the market's daily record. Each figure spans the report date — from the last session that closed before it to the first that closed after — because a company may report before the open or after the close.
Fundamentals
| Metric | Value | Period |
|---|---|---|
| Gross margin | 85.3% | Trailing 12 months |
| Operating margin | 15.5% | Trailing 12 months |
| Net profit margin | 8.8% | Trailing 12 months |
| Pretax margin | 12.7% | Trailing 12 months |
| EPS | $29.87 | Trailing 12 months |
| Revenue growth (YoY) | 7.3% | Trailing 12 months |
| EPS growth (YoY) | 25.5% | Trailing 12 months |
| Return on equity | 695.7% | Trailing 12 months |
Sources: company report · earnings call